CUV 2.80% $13.19 clinuvel pharmaceuticals limited

now this really sux, page-12

  1. 3,045 Posts.
    Hi SC, I have to say I agree... I think it will take something special to get back the speculators in droves, they seem to be creating a right fuss with the likes of PRR at the moment. I'm tipping EU approval could do it, phase III trials (if positive) should get the ball rolling.

    It's an amazing stock, once they get approval I can just see all the back of the envelope calculations coming out of the woodwork.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.